Acquired Factor XIII Deficiency Is Common during ECMO Therapy and Associated with Major Bleeding Events and Transfusion Requirements

Background: Bleeding events are frequent complications during extracorporeal membrane oxygenation therapy (ECMO). Objective: To determine the rate of acquired factor XIII deficiency and its association with major bleeding events and transfusion requirements in adults undergoing ECMO therapy. Materia...

Descripción completa

Detalles Bibliográficos
Autores principales: Noitz, Matthias, Brooks, Roxane, Szasz, Johannes, Jenner, Dennis, Böck, Carl, Krenner, Niklas, Dünser, Martin W., Meier, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299514/
https://www.ncbi.nlm.nih.gov/pubmed/37373805
http://dx.doi.org/10.3390/jcm12124115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299514/
https://www.ncbi.nlm.nih.gov/pubmed/37373805
http://dx.doi.org/10.3390/jcm12124115

Ejemplares similares